Piller is an investigative journalist for Science. In November 2022, Dennis Selkoe, a Harvard professor of neurologic diseases and among the most celebrated and prolific Alzheimer’s researchers ...

In “Doctored,” Charles Piller uncovers evidence that many important Alzheimer’s studies are based on faulty data.

All study participants also provided cerebrospinal fluid (CSF) samples for amyloid beta (Aβ) and tau protein assessment ...

The highest tertile of REM sleep latency was associated with a higher burden of amyloid-beta (β=0.08 ... Participants had a mean age of 70.8 years, and 56.9% were women. They were assessed ...

56.9% women) from the outpatient neurology unit of the China-Japan Friendship Hospital between September 2022 and July 2023. Participants underwent overnight polysomnography and amyloid-beta ...

A reporter uncovers evidence that research fraud on a massive scale has hyped the potential benefit of expensive drugs aimed at slowing or reversing the mental decline of patients with Alzheimer’s ...

Empowered Funds LLC bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought ...

Deutsche Bank Aktiengesellschaft started coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Get Free Report) in a research note issued to investors on Tuesday, Ratings reports. The firm set a ...

The healthiest olive oils are packed with heart-supporting polyphenols and omega-3 fatty acids. We tested and rated 13 ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on ...

Background: Amyloid-related Imaging Abnormalities (ARIA) are adverse effects that occur during amyloid beta monoclonal antibody treatment for Alzheimer's disease, including edema-type ARIA and ...